Cargando…
The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients
PURPOSE: The age-adjusted Charlson comorbidity index (ACCI) is a useful measure of comorbidity to standardize the evaluation of elderly patients and has been reported to predict mortality in various cancers. To our best knowledge, no studies have examined the relationship between the ACCI and surviv...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091471/ https://www.ncbi.nlm.nih.gov/pubmed/35573259 http://dx.doi.org/10.2147/CMAR.S361495 |
_version_ | 1784704931607871488 |
---|---|
author | Zhou, Shi Zhang, Xing-Hu Zhang, Yuan Gong, Ge Yang, Xiang Wan, Wen-Hui |
author_facet | Zhou, Shi Zhang, Xing-Hu Zhang, Yuan Gong, Ge Yang, Xiang Wan, Wen-Hui |
author_sort | Zhou, Shi |
collection | PubMed |
description | PURPOSE: The age-adjusted Charlson comorbidity index (ACCI) is a useful measure of comorbidity to standardize the evaluation of elderly patients and has been reported to predict mortality in various cancers. To our best knowledge, no studies have examined the relationship between the ACCI and survival of elderly patients with cancer. Therefore, the primary objective of this study was to investigate the relationship between the ACCI and survival of elderly patients with cancer. PATIENTS AND METHODS: A total of 64 elderly patients (>80 years) with cancer between 2011 and 2021 were enrolled in this study. According to the ACCI, the age-adjusted comorbidity index was calculated by weighting individual comorbidities; patients with ACCI<11 were considered the low-ACCI group, whereas those with ACCI≥11 were considered the high-ACCI group. The correlations between the ACCI score and survival outcomes were statistically analyzed. RESULTS: There was a significant difference in overall survival (OS) and progression-free survival (PFS) between the high-ACCI group and the low-ACCI group (P<0.001). The median OS time of the high-ACCI group and the low-ACCI group were 13.9 (10.5–22.0) months and 51.9 (34.1–84.0) months, respectively. The 2-, 3-, and 5-year survival rates of the high-ACCI group were 28.1%, 18.8%, and 4.2%, respectively, whereas the 2-, 3-, and 5-year survival rates of the low-ACCI group were 77.3%, 66.4%, and 39.1%, respectively. Multivariate analysis showed that ACCI was independently associated with OS (HR=1.402, 95% CI: 1.226–1.604, P < 0.05) and PFS (HR=1.353, 95% CI: 1.085–1.688, P = 0.0073). CONCLUSION: The ACCI score is a significant independent predictor of prognosis in elderly patients with cancer. |
format | Online Article Text |
id | pubmed-9091471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-90914712022-05-12 The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients Zhou, Shi Zhang, Xing-Hu Zhang, Yuan Gong, Ge Yang, Xiang Wan, Wen-Hui Cancer Manag Res Original Research PURPOSE: The age-adjusted Charlson comorbidity index (ACCI) is a useful measure of comorbidity to standardize the evaluation of elderly patients and has been reported to predict mortality in various cancers. To our best knowledge, no studies have examined the relationship between the ACCI and survival of elderly patients with cancer. Therefore, the primary objective of this study was to investigate the relationship between the ACCI and survival of elderly patients with cancer. PATIENTS AND METHODS: A total of 64 elderly patients (>80 years) with cancer between 2011 and 2021 were enrolled in this study. According to the ACCI, the age-adjusted comorbidity index was calculated by weighting individual comorbidities; patients with ACCI<11 were considered the low-ACCI group, whereas those with ACCI≥11 were considered the high-ACCI group. The correlations between the ACCI score and survival outcomes were statistically analyzed. RESULTS: There was a significant difference in overall survival (OS) and progression-free survival (PFS) between the high-ACCI group and the low-ACCI group (P<0.001). The median OS time of the high-ACCI group and the low-ACCI group were 13.9 (10.5–22.0) months and 51.9 (34.1–84.0) months, respectively. The 2-, 3-, and 5-year survival rates of the high-ACCI group were 28.1%, 18.8%, and 4.2%, respectively, whereas the 2-, 3-, and 5-year survival rates of the low-ACCI group were 77.3%, 66.4%, and 39.1%, respectively. Multivariate analysis showed that ACCI was independently associated with OS (HR=1.402, 95% CI: 1.226–1.604, P < 0.05) and PFS (HR=1.353, 95% CI: 1.085–1.688, P = 0.0073). CONCLUSION: The ACCI score is a significant independent predictor of prognosis in elderly patients with cancer. Dove 2022-05-06 /pmc/articles/PMC9091471/ /pubmed/35573259 http://dx.doi.org/10.2147/CMAR.S361495 Text en © 2022 Zhou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Zhou, Shi Zhang, Xing-Hu Zhang, Yuan Gong, Ge Yang, Xiang Wan, Wen-Hui The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients |
title | The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients |
title_full | The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients |
title_fullStr | The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients |
title_full_unstemmed | The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients |
title_short | The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients |
title_sort | age-adjusted charlson comorbidity index predicts prognosis in elderly cancer patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091471/ https://www.ncbi.nlm.nih.gov/pubmed/35573259 http://dx.doi.org/10.2147/CMAR.S361495 |
work_keys_str_mv | AT zhoushi theageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT zhangxinghu theageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT zhangyuan theageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT gongge theageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT yangxiang theageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT wanwenhui theageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT zhoushi ageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT zhangxinghu ageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT zhangyuan ageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT gongge ageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT yangxiang ageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients AT wanwenhui ageadjustedcharlsoncomorbidityindexpredictsprognosisinelderlycancerpatients |